These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28981872)

  • 1. Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families.
    Renault AL; Mebirouk N; Cavaciuti E; Le Gal D; Lecarpentier J; d'Enghien CD; Laugé A; Dondon MG; Labbé M; Lesca G; Leroux D; Gladieff L; Adenis C; Faivre L; Gilbert-Dussardier B; Lortholary A; Fricker JP; Dahan K; Bay JO; Longy M; Buecher B; Janin N; Zattara H; Berthet P; Combès A; Coupier I; ; Hall J; Stoppa-Lyonnet D; Andrieu N; Lesueur F
    Carcinogenesis; 2017 Oct; 38(10):994-1003. PubMed ID: 28981872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.
    van Os NJ; Roeleveld N; Weemaes CM; Jongmans MC; Janssens GO; Taylor AM; Hoogerbrugge N; Willemsen MA
    Clin Genet; 2016 Aug; 90(2):105-17. PubMed ID: 26662178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries.
    Olsen JH; Hahnemann JM; Børresen-Dale AL; Brøndum-Nielsen K; Hammarström L; Kleinerman R; Kääriäinen H; Lönnqvist T; Sankila R; Seersholm N; Tretli S; Yuen J; Boice JD; Tucker M
    J Natl Cancer Inst; 2001 Jan; 93(2):121-7. PubMed ID: 11208881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataxia-telangiectasia genes and breast cancer risk in a French family study.
    Andrieu N; Cavaciuti E; Laugé A; Ossian K; Janin N; Hall J; Stoppa-Lyonnet D
    J Dairy Res; 2005; 72 Spec No():73-80. PubMed ID: 16180724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
    Renault AL; Mebirouk N; Fuhrmann L; Bataillon G; Cavaciuti E; Le Gal D; Girard E; Popova T; La Rosa P; Beauvallet J; Eon-Marchais S; Dondon MG; d'Enghien CD; Laugé A; Chemlali W; Raynal V; Labbé M; Bièche I; Baulande S; Bay JO; Berthet P; Caron O; Buecher B; Faivre L; Fresnay M; Gauthier-Villars M; Gesta P; Janin N; Lejeune S; Maugard C; Moutton S; Venat-Bouvet L; Zattara H; Fricker JP; Gladieff L; Coupier I; ; ; ; Chenevix-Trench G; Hall J; Vincent-Salomon A; Stoppa-Lyonnet D; Andrieu N; Lesueur F
    Breast Cancer Res; 2018 Apr; 20(1):28. PubMed ID: 29665859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risks and mortality in heterozygous ATM mutation carriers.
    Thompson D; Duedal S; Kirner J; McGuffog L; Last J; Reiman A; Byrd P; Taylor M; Easton DF
    J Natl Cancer Inst; 2005 Jun; 97(11):813-22. PubMed ID: 15928302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer risk in heterozygotes for ataxia-telangiectasia.
    Geoffroy-Perez B; Janin N; Ossian K; Laugé A; Croquette MF; Griscelli C; Debré M; Bressac-de-Paillerets B; Aurias A; Stoppa-Lyonnet D; Andrieu N
    Int J Cancer; 2001 Jul; 93(2):288-93. PubMed ID: 11410879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families.
    Cavaciuti E; Laugé A; Janin N; Ossian K; Hall J; Stoppa-Lyonnet D; Andrieu N
    Genes Chromosomes Cancer; 2005 Jan; 42(1):1-9. PubMed ID: 15390180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole genome joint analysis reveals ATM:C.1564_1565del variant segregating with Ataxia-Telangiectasia and breast cancer.
    Ćuk M; Unal B; Hayes CP; Walker M; Bevanda A; Antolović V; Ghazani AA
    Cancer Genet; 2024 Aug; 286-287():43-47. PubMed ID: 39067332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis.
    Ratnaparkhe M; Hlevnjak M; Kolb T; Jauch A; Maass KK; Devens F; Rode A; Hovestadt V; Korshunov A; Pastorczak A; Mlynarski W; Sungalee S; Korbel J; Hoell J; Fischer U; Milde T; Kramm C; Nathrath M; Chrzanowska K; Tausch E; Takagi M; Taga T; Constantini S; Loeffen J; Meijerink J; Zielen S; Gohring G; Schlegelberger B; Maass E; Siebert R; Kunz J; Kulozik AE; Worst B; Jones DT; Pfister SM; Zapatka M; Lichter P; Ernst A
    Leukemia; 2017 Oct; 31(10):2048-2056. PubMed ID: 28196983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers.
    Laitman Y; Boker-Keinan L; Berkenstadt M; Liphsitz I; Weissglas-Volkov D; Ries-Levavi L; Sarouk I; Pras E; Friedman E
    Cancer Genet; 2016 Mar; 209(3):70-4. PubMed ID: 26778106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
    Pylkäs K; Tommiska J; Syrjäkoski K; Kere J; Gatei M; Waddell N; Allinen M; Karppinen SM; Rapakko K; Kääriäinen H; Aittomäki K; Blomqvist C; Mustonen A; Holli K; Khanna KK; Kallioniemi OP; Nevanlinna H; Winqvist R
    Carcinogenesis; 2007 May; 28(5):1040-5. PubMed ID: 17166884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia.
    Olsen JH; Hahnemann JM; Børresen-Dale AL; Tretli S; Kleinerman R; Sankila R; Hammarström L; Robsahm TE; Kääriäinen H; Bregård A; Brøndum-Nielsen K; Yuen J; Tucker M
    Br J Cancer; 2005 Jul; 93(2):260-5. PubMed ID: 15942625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.
    Spring K; Ahangari F; Scott SP; Waring P; Purdie DM; Chen PC; Hourigan K; Ramsay J; McKinnon PJ; Swift M; Lavin MF
    Nat Genet; 2002 Sep; 32(1):185-90. PubMed ID: 12195425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATM mutations for surgeons.
    Mansfield SA; Pilarski R; Agnese DM
    Fam Cancer; 2017 Jul; 16(3):407-410. PubMed ID: 27988859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ataxia-telangiectasia gene (
    Jerzak KJ; Mancuso T; Eisen A
    Curr Oncol; 2018 Apr; 25(2):e176-e180. PubMed ID: 29719442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study.
    Tamimi RM; Hankinson SE; Spiegelman D; Kraft P; Colditz GA; Hunter DJ
    Breast Cancer Res; 2004; 6(4):R416-22. PubMed ID: 15217510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.
    Broeks A; Urbanus JH; de Knijff P; Devilee P; Nicke M; Klöpper K; Dörk T; Floore AN; van't Veer LJ
    Hum Mutat; 2003 May; 21(5):521-8. PubMed ID: 12673794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast and other cancers in families with ataxia-telangiectasia.
    Swift M; Reitnauer PJ; Morrell D; Chase CL
    N Engl J Med; 1987 May; 316(21):1289-94. PubMed ID: 3574400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study.
    Pavanello S; Varesco L; Gismondi V; Bruzzi P; Bolognesi C
    PLoS One; 2018; 13(5):e0197522. PubMed ID: 29782524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.